ILSI-Biomed Israel

A film which explains about a new therapeutic vaccine for cancer – amazing!

Here is the film which explains about ImMucin, a new therapeutic vaccine for cancer which is currently in clinical trials in Myeloma patients. You are also invited to visit Vaxil BioTherapeutics site. Tweet

Startup Weekly: ProtAb – Antibodies Against Arthritis

ProtAb is a company dedicated to eveloping an antibody for the treatment of Rheumatoid Arthritis and other autoimmune diseases such as Crohn's Disease, and has recently raised $4 million. Name: ProtAb CEO: Shira Yair Sector: Biopharma Medical Field: Autoimmune Diseases Est.: 2005 Stage: Late stage pre-clinical, after series A funding Vision: To develop a novel therapeutics for autoimmune diseases, based on the induction of natural anti-inflammatory mechanisms existing in...

Meet the Speakers: A Seminar about Vaccines in ILSI-BioMed 2010 Week

How will the panel of vaccine experts handle the recent developments in vaccine situations, such as Wakefield's article rennouncement by The Lancet, or the Swine Influenza vaccine? Greetings, dear readers! I'm happy to present a new section of this blog, termed Meet the Speakers. Every week, we'll introduce another of the lecturers and panelists in the up-and-coming ILSI-BioMed 2010 week. I hope it makes for an interesting reading! The last year, as well as the current one, has seen so...

Asthma Relief Inhalers Might Make Asthma Worse?

A new study at the University of Leicester is probing why asthma relief inhalers might actually make asthma worse - and what can be done about it Ever since the industrial revolution, asthma has become one of the most common medical conditions in the world, with an estimated 300 million people suffering from the condition worldwide. Being an asthmatic myself, I know that currently there is no cure for asthma, although there are 'relievers' – usually inhalers that relieve asthma symptoms by re...

Almost-Breakthroughs of the Year: Genetic Engineering and Longevity Drug

The magazine Science picked two runner-ups for the Breakthrough of the Year award: genetic engineering and a novel longevity drug Do you read Science, the magazine? You really should. It's one of the best sources for breakthroughs in research. This month they have a special section, where they tried to pick the Breakthrough of the Year. They probably had to do quite a lot of thinking, but eventually they settles on the discovery of Ardi - the missing link between our ancient ape-like ance...

Study Redefines Placebo Effect as Part of Effective Treatment

A new study redefines placebo effect as part of effective treatment in psoriasis, by treating patients with one quarter of their usual dose. The placebo effect is one of the most confounding aspects of every medical drug. When I’m taking this paracetamol – is it the drug doing the work, or is my brain fooling me? Both, most probably. But how much of each? And can we design drugs that will make smart use of the placebo effect? Well, such drugs exist already, as homeopathic remedies whic...

Of Aging and the Universal Flu Vaccine

Two interesting headlines in Calcalist: in five years we'll get to know our approximated life expectency, and if everything goes alright, we'll have a universal Flu Vaccine  to boot. There’ve been two interesting articles in Calcalist (the Israeli Economist), lately. I really recommend reading this paper, as it has some quality articles appearing every few days. The first deals with the aging world, which is a topic that has vast ramifications on the economy, society and healthcare, espec...

Cancer Vaccine on the Way?

Successful experiments on mice show promise for the development of a vaccine against cancer. We live in the era of the vaccines. It has been just a little over two hundred years since the first vaccine was invented against smallpox, and eventually eradicated the disease from the face of the earth. Since then, vaccines were devised against many kinds of diseases, which are almost nonexistent today. Now, a new type of vaccine is being developed, and may serve as the turning point of the wa...